Search

everythinglearnresearchcommunity

for

Search:↓

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Targeted cancer therapies often cause serious skin problems that need careful management.

EF and PXE not closely related.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Janus kinase inhibitors may help treat lichen planopilaris.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Blocking the JAK/STAT pathway may help reduce skin sensitivity in Xeroderma pigmentosum.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

QLT0267 stops hair follicle cell growth and movement.

A new compound effectively inhibits human 5α-reductase 1.

A new therapy for a skin blistering condition has not been developed yet.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.